Amanote Research
Register
Sign In
Evaluation of Breast Cancer HER2 Status Accuracy Using a Predictive Model Based on Her-France Real World National Database
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.09.1944
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2016
Authors
C Egele
D Pau
J Rabut
D Fetique
J Martin
J Bellocq
Publisher
Elsevier BV
Related search
Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis
Scientific Reports
Multidisciplinary
ID3014 Evaluation of HER2 Status in Breast Cancer: Current Status and Future Directions
Biomedical Research and Therapy
Biochemistry
Medicine
Genetics
Molecular Biology
Neoadjuvant Treatment of HER2-positive Breast Cancer: Should Therapy Differ Based on Hormone Receptor Status?
Therapeutic Advances in Medical Oncology
Oncology
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
European Journal of Breast Health
Real-World Efficacy and Safety of Eribulin in Advanced and Pretreated HER2-negative Breast Cancer in a Spanish Comprehensive Cancer Center
BMC pharmacology & toxicology
Medicine
Pharmacology
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Cancer Discovery
Oncology
A National Cancer Database Study on Intra-Operative Radiation Therapy in Breast Cancer Patients: Does Socioeconomic Status or Race Correlate With Cure?
Surgery: Current Research
Accuracy of HER2 Status Determination on Breast Core-Needle Biopsies (Immunohistochemistry, FISH, CISH and SISH vs FISH)
Modern Pathology
Forensic Medicine
Pathology
